SCHEMBL1745181

SCHEMBL1745181

CS(=O)(=O)NCCCc1ccc(OC2CCc3cc(Cl)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
SLC6A9 P48067 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
GRIN2B Q13224 6/20 0.40
GRIN1 Q05586 2/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
SLC6A4 P31645 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
MAPT P10636 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1746947 0.84 ACACB (0.45) GRIN2B
SCHEMBL1744565 0.83 TRPV1 (0.42) TRPV1MAPTALDH1A1GAAKDM5A
SCHEMBL1746743 0.78 KDM5A (0.40) SLC6A4KDM5AKDM4CKDM5BFFAR1
SCHEMBL1745475 0.76 FFAR1 (0.50) SLC6A4KDM5AKDM4CKDM5BFFAR1
SCHEMBL1746551 0.75 KDM5A (0.41) SLC6A4PDE4BKDM5AKDM4CKDM5B
SCHEMBL1747113 0.75 SLC6A4 (0.41) GRIN2BDDB1CRBNSLC6A4KDM5A
SCHEMBL1744691 0.71 HRH3 (0.42) MAPTALDH1A1FFAR1FFAR4
SCHEMBL9966871 0.69 KDM5A (0.55) SLC6A4ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL12019265 0.69 FFAR1 (0.47) POLBTRPV1SLC6A4MAPTKDM5A
SCHEMBL1747248 0.69 GRIN2B (0.44) POLBGRIN2BGRIN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR POLB 4877/4885SLC6A9 2171/4885TRPV1 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.